Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week

R. Ferreiro-Iglesias; A. Jardi; A. Quiroga; I. Baston; J. Gonzalez; J. M. Giraldez; I. Zarra; M. J. Lamas; J. E. Dominguez-Munoz; M. Barreiro-de Acosta

Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week

R. Ferreiro-Iglesias, A. Jardi, A. Quiroga, I. Baston, J. Gonzalez, J. M. Giraldez, I. Zarra, M. J. Lamas, J. E. Dominguez-Munoz, M. Barreiro-de Acosta

Departamento de Psicología

Producción científica › revisión exhaustiva

Idioma original	English
Páginas (desde-hasta)	S390-S391
Publicación	Journal of Crohn's and Colitis
Volumen	13
Estado	Published - mar 2019

Citar esto

Ferreiro-Iglesias, R., Jardi, A., Quiroga, A., Baston, I., Gonzalez, J., Giraldez, J. M., Zarra, I., Lamas, M. J., Dominguez-Munoz, J. E., & Barreiro-de Acosta, M. (2019). Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week. Journal of Crohn's and Colitis, 13, S390-S391.

@article{ff6fe3baa6ab4cdbb43aba6d3b02e418,

title = "Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week",

author = "R. Ferreiro-Iglesias and A. Jardi and A. Quiroga and I. Baston and J. Gonzalez and Giraldez, {J. M.} and I. Zarra and Lamas, {M. J.} and Dominguez-Munoz, {J. E.} and {Barreiro-de Acosta}, M.",

year = "2019",

month = mar,

language = "English",

volume = "13",

pages = "S390--S391",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

}

Ferreiro-Iglesias, R, Jardi, A, Quiroga, A, Baston, I, Gonzalez, J, Giraldez, JM, Zarra, I, Lamas, MJ, Dominguez-Munoz, JE & Barreiro-de Acosta, M 2019, 'Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week', Journal of Crohn's and Colitis, vol. 13, pp. S390-S391.

TY - JOUR

T1 - Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week

AU - Ferreiro-Iglesias, R.

AU - Jardi, A.

AU - Quiroga, A.

AU - Baston, I.

AU - Gonzalez, J.

AU - Giraldez, J. M.

AU - Zarra, I.

AU - Lamas, M. J.

AU - Dominguez-Munoz, J. E.

AU - Barreiro-de Acosta, M.

PY - 2019/3

Y1 - 2019/3

M3 - Meeting Abstract

SN - 1873-9946

VL - 13

SP - S390-S391

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

ER -